Protective Effect of “ Ark‐e‐Kasni ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats
Journal of Obstetrics and Gynaecology Research · 2026-03 · 52 (3)
DOI: 10.1111/jog.70228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 09.03.2026. Verfasst von Kamini R Shirasath und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India, Ministry of AYUSH, Government of India.
Abstract (Originalsprache)
Aim
The present study aimed to evaluate the therapeutic potential of the Unani formulation Ark‐e‐Kasni in alleviating the symptoms of polycystic ovary syndrome (PCOS).
Methods
In the present study, letrozole and a high‐fat diet (HFD) were used to induce PCOS‐like symptoms in rats. After induction, different groups were treated with varying doses of Ark‐e‐Kasni (5, 10, and 20 mL/kg), metformin, and finasteride. At the end of treatment, blood and ovaries were collected for biochemical and histological analysis.
Results
A significant weight gain and prolonged diestrous phase were observed in PCOS rats, accompanied by a considerable elevation in LH (42.52 ± 0.90 mIU/mL) and testosterone (8370 ± 122.18 pg/mL), and a low level of FSH (11.86 ± 0.43 mIU/mL). Moreover, an increase in insulin (14.31 ± 0.35 mIU/mL), TNF‐α (358.81 ± 9.81 pg/mL), IL‐1β (143.74 ± 3.39 pg/mL), and IL‐6 (154.04 ± 2.04 pg/mL), and a reduction in SOD, CAT, and GSH were noticed. While the Ark‐e‐Kasni restored the levels of LH (30.97 ± 1.04 mIU/mL), testosterone (5651.83 ± 182.69 pg/mL), FSH (15.66 ± 0.56 mIU/mL), insulin (5.48 ± 0.23 mIU/mL), TNF‐α (212.16 ± 8.66 pg/mL), IL‐1β (78.79 ± 1.46 pg/mL), and IL‐6 (74.53 ± 1.60 pg/mL), and lipid markers. Histological and microscopic analysis showed reduced cystic follicles and enhanced corpus luteum formation, improving ovarian morphology.
Conclusion
The findings suggest that Ark‐e‐Kasni ameliorates PCOS through diverse molecular mechanisms. Ark‐e‐Kasni may modulate steroidogenic enzyme activity to reduce hyperandrogenism, enhance insulin sensitivity through the PI3K/Akt pathway, and inhibit the downstream inflammatory pathway of NF‐κB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, India.
- Central Council for Research in Unani Medicine (CCRUM), New Delhi, India.
- Regional Research Institute of Unani Medicine (RRIUM), Navi Mumbai, India.
- Department of Pharmaceutics, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, India.
ORCID-Profile: Yogeeta O Agrawal
Förderung
- Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India
- Ministry of AYUSH, Government of India
Zitieren
APA
Shirasath, K. R., Karwasra, R., Ahmed, N. Z., Kumar, P., Alam, S., Goyal, S. N., & Agrawal, Y. O. (2026). Protective Effect of “ Ark‐e‐Kasni ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats. Journal of Obstetrics and Gynaecology Research, 52(3). https://doi.org/10.1111/jog.70228
Vancouver
Shirasath KR, Karwasra R, Ahmed NZ, Kumar P, Alam S, Goyal SN, et al. Protective Effect of “ Ark‐e‐Kasni ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats. Journal of Obstetrics and Gynaecology Research. 2026;52(3). doi:10.1111/jog.70228
BibTeX
@article{Shirasath2026,
author = {Shirasath, Kamini R and Karwasra, Ritu and Ahmed, N Zaheer and Kumar, Pawan and Alam, Shah and Goyal, Sameer N and Agrawal, Yogeeta O},
title = {Protective Effect of “ Ark‐e‐Kasni ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {3},
doi = {10.1111/jog.70228}
}
EUVIMED